Zevra Therapeutics (ZVRA) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of$0.21. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 71.43$0.39 per share when it actually produced a loss of $0.67, delivering a surprise of -71.79%.Over the last four quart ...